BlackRock Inc. lessened its holdings in LivaNova PLC (NASDAQ:LIVN – Get Rating) by 0.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,414,761 shares of the company’s stock after selling 10,371 shares during the quarter. BlackRock Inc. owned approximately 11.99% of LivaNova worth $325,679,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Western Pacific Wealth Management LP purchased a new position in shares of LivaNova during the third quarter worth about $44,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of LivaNova by 29.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 787 shares of the company’s stock worth $49,000 after purchasing an additional 180 shares during the last quarter. Picton Mahoney Asset Management purchased a new position in shares of LivaNova during the third quarter worth about $70,000. Wolverine Asset Management LLC grew its holdings in shares of LivaNova by 35.3% during the third quarter. Wolverine Asset Management LLC now owns 1,454 shares of the company’s stock worth $73,000 after purchasing an additional 379 shares during the last quarter. Finally, Point72 Hong Kong Ltd purchased a new position in shares of LivaNova during the third quarter worth about $85,000. Hedge funds and other institutional investors own 98.89% of the company’s stock.
Insider Activity at LivaNova
In related news, CEO Damien Mcdonald sold 2,220 shares of the firm’s stock in a transaction dated Thursday, December 15th. The shares were sold at an average price of $54.56, for a total value of $121,123.20. Following the completion of the sale, the chief executive officer now owns 83,749 shares in the company, valued at $4,569,345.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.38% of the stock is owned by insiders.
LivaNova Price Performance
LivaNova (NASDAQ:LIVN – Get Rating) last announced its quarterly earnings data on Wednesday, February 22nd. The company reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.72 by $0.09. The firm had revenue of $274.90 million during the quarter, compared to the consensus estimate of $262.16 million. LivaNova had a negative net margin of 8.44% and a positive return on equity of 10.49%. The firm’s revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.57 earnings per share. Research analysts predict that LivaNova PLC will post 2.58 earnings per share for the current year.
Analyst Ratings Changes
Several equities analysts have issued reports on LIVN shares. StockNews.com raised LivaNova from a “hold” rating to a “buy” rating in a report on Monday, December 19th. Barclays began coverage on shares of LivaNova in a research note on Wednesday, December 21st. They set an “equal weight” rating and a $62.00 target price for the company. Finally, The Goldman Sachs Group decreased their target price on shares of LivaNova from $73.00 to $63.00 and set a “buy” rating for the company in a research note on Wednesday, November 23rd. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $76.20.
LivaNova Profile
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiovascular and Neuromodulation segments. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and circulatory support products.
Read More
- Get a free copy of the StockNews.com research report on LivaNova (LIVN)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN – Get Rating).
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
